¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤) : 2022-05-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤) : 2022-05-28
±³À°ÀÏÀÚ : 2022-05-28
±³À°Àå¼Ò : ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : 2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤)
ÁÖÃÖ±â°ü : ´ëÇѼҾư¨¿°ÇÐȸ
´ã´çÀÚ : ±è¿µ¶õ
¿¬¶ôó : 02-3478-1668  
À̸ÞÀÏ : kspid@kspid.or.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡   (ÀÏ¹Ý 4Á¡ / Çʼö 1Á¡)  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í È¸¿ø: 40,000¿øºñȸ¿ø: 60,000¿øÀü°øÀÇ ¹× Çлý: 10,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ10:00~10:30 Recent advances in prevention of RSV in young infants  À±±â¿í(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ10:30~11:00 Advances in development of Influenza vaccines  ±èÀ±°æ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ11:00~11:30 Prevention strategies for CMV infection  ÀÌÁø¾Æ(¿ï»êÀÇ´ë) 
±âŸ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ11:30~12:00 ÃÑȸ  () 
½Ä»ç 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ12:00~13:00 Á߽Ġ () 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ13:00~13:40 Past, present, and future of mRNA vaccines  Á¶´ë¼±/TBD(ÀüºÏÀÇ´ë/Moderna) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ13:40~14:20 COVID-19 in children and pregnant women in Japan  Kensuke Shoji(National Center for Child Health and Development) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ14:20~15:00 Clinical features of COVID-19 in children in Korea  Çѹ̼±(¼­¿ïÀÇ´ë) 
È޽Ġ05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ15:00~15:20 È޽Ġ () 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ15:20~15:50 Issues on COVID-19 vaccines in children: effectiveness, safety and goals  ÃÖ¿µÁØ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ15:50~16:20 Surveillance during the COVID-19 pandemic: modeling and monitoring  Á¤ÀçÈÆ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ16:20~16:50 Reflecting on infection control measures in COVID-19: what was necessary and what was not?  Á¶Çý°æ(°¡ÃµÀÇ´ë) 
±âŸ 05-28 ÇѾç´ëÇб³ HIT ´ëȸÀǽǠ16:50~17:00 Çмú³í¹®»ó ¹× PIV ¿ì¼ö ½É»çÀ§¿ø»ó ¼ö»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ(°¨¿°°ü¸®¿¬¼ö±³À° 5½Ã°£ ÀÎÁ¤) : 2022-05-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â Á¦ 82Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2022-05-29
´ÙÀ½±Û 2022 Çѱ¹¸ðÀÚº¸°ÇÇÐȸ Á¦50ȸ Ãá°è¿¬¼ö°­Á : 2022-05-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 4 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 8 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 9 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 8 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 5 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 8 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 9 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 9 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 5 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 2 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 4 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 8 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 3 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 4 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 5 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷